You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

NORETHINDRONE AND ETHINYL ESTRADIOL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Norethindrone And Ethinyl Estradiol, and when can generic versions of Norethindrone And Ethinyl Estradiol launch?

Norethindrone And Ethinyl Estradiol is a drug marketed by Watson Labs, Watson Pharms Teva, Dr Reddys Labs Sa, Mylan Labs Ltd, Naari Pte Ltd, Watson Labs Teva, Xiromed, Teva Branded Pharm, Amneal Pharms, Barr, and Lupin Ltd. and is included in twenty-four NDAs.

The generic ingredient in NORETHINDRONE AND ETHINYL ESTRADIOL is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for NORETHINDRONE AND ETHINYL ESTRADIOL?
  • What are the global sales for NORETHINDRONE AND ETHINYL ESTRADIOL?
  • What is Average Wholesale Price for NORETHINDRONE AND ETHINYL ESTRADIOL?
Summary for NORETHINDRONE AND ETHINYL ESTRADIOL
Drug patent expirations by year for NORETHINDRONE AND ETHINYL ESTRADIOL
Recent Clinical Trials for NORETHINDRONE AND ETHINYL ESTRADIOL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of VirginiaEarly Phase 1
Achillion, a wholly owned subsidiary of AlexionPhase 1
Alexion PharmaceuticalsPhase 1

See all NORETHINDRONE AND ETHINYL ESTRADIOL clinical trials

US Patents and Regulatory Information for NORETHINDRONE AND ETHINYL ESTRADIOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs NORETHINDRONE AND ETHINYL ESTRADIOL ethinyl estradiol; norethindrone TABLET;ORAL-21 078379-001 Feb 23, 2010 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva Branded Pharm NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE ethinyl estradiol; norethindrone TABLET, CHEWABLE;ORAL 022573-001 Dec 22, 2010 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Xiromed NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE ethinyl estradiol; norethindrone TABLET;ORAL 202086-001 Apr 1, 2015 AB RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mylan Labs Ltd NORETHINDRONE AND ETHINYL ESTRADIOL ethinyl estradiol; norethindrone TABLET;ORAL-28 200489-001 Oct 21, 2015 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Dr Reddys Labs Sa NORETHINDRONE AND ETHINYL ESTRADIOL ethinyl estradiol; norethindrone TABLET;ORAL-28 070686-001 Jan 29, 1987 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.